Quarterly report pursuant to Section 13 or 15(d)

Segments - Operations and Assets Information (Details)

v3.8.0.1
Segments - Operations and Assets Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Dec. 31, 2016
Segment Reporting Information [Line Items]          
Revenue from services $ 229,035 $ 259,025 $ 740,992 $ 777,559  
Product revenues 22,795 20,569 73,992 63,275  
Revenue from transfer of intellectual property and other 11,665 18,441 58,819 105,338  
Operating loss (58,290) (23,623) (126,440) (22,875)  
Depreciation and amortization 25,394 25,832 76,677 72,612  
Net income (loss) from investment in investees (4,013) (814) (11,771) (5,147)  
Revenues 263,495 298,035 873,803 946,172  
Assets 2,721,990   2,721,990   $ 2,766,619
Goodwill 715,573   715,573   704,603
United States          
Segment Reporting Information [Line Items]          
Revenues 229,218 259,221 751,732 777,703  
Ireland          
Segment Reporting Information [Line Items]          
Revenues 15,182 20,594 57,812 114,526  
Chile          
Segment Reporting Information [Line Items]          
Revenues 11,514 9,936 33,534 26,516  
Spain          
Segment Reporting Information [Line Items]          
Revenues 4,123 3,910 13,746 12,257  
Israel          
Segment Reporting Information [Line Items]          
Revenues 1,935 3,699 13,807 12,862  
Mexico          
Segment Reporting Information [Line Items]          
Revenues 1,483 675 3,072 2,308  
Other          
Segment Reporting Information [Line Items]          
Revenues 40 0 100 0  
Corporate          
Segment Reporting Information [Line Items]          
Revenue from services 0 0 0 0  
Revenue from transfer of intellectual property and other 0 0 0 0  
Operating loss (12,219) (8,128) (41,067) (49,414)  
Depreciation and amortization 29 20 90 60  
Net income (loss) from investment in investees 0 0 0 0  
Assets 72,939   72,939   63,181
Goodwill 0   0   0
Pharmaceutical | Operating Segments          
Segment Reporting Information [Line Items]          
Revenue from services 0 0 0 0  
Product revenues 22,795 20,569 73,992 63,275  
Revenue from transfer of intellectual property and other 11,665 18,441 58,819 105,338  
Operating loss (18,452) (18,593) (49,709) 15,422  
Depreciation and amortization 6,935 6,994 20,404 12,841  
Net income (loss) from investment in investees (3,661) 399 (10,784) (5,643)  
Assets 1,309,650   1,309,650   1,294,916
Goodwill 262,786   262,786   251,817
Diagnostics | Operating Segments          
Segment Reporting Information [Line Items]          
Revenue from services 229,035 259,025 740,992 777,559  
Revenue from transfer of intellectual property and other 0 0 0 0  
Operating loss (27,619) 3,098 (35,664) 11,117  
Depreciation and amortization 18,430 18,818 56,183 59,711  
Net income (loss) from investment in investees (352) $ (1,213) (987) $ 496  
Assets 1,339,401   1,339,401   1,408,522
Goodwill $ 452,787   $ 452,787   $ 452,786